On Dec. 2nd, 2020, Torch High Technology Industry Development Center, Ministry of Science and Technology posts the List of the Fourth Batch of High Tech Enterprises to Be Identified. With the professional R & D team, strong technical strength and continuous innovation ability, Hanyi Biotechnology (Beijing) Co., Ltd. (hereinafter referred to as “HYBT”) is once again listed in the "fourth batch of high-tech enterprises in Beijing" after being approved as "national high-tech enterprises".
The identification of high-tech enterprises is an important proof that the enterprises own the ability of continuous research and development, transformation of technological achievements and formation of core independent intellectual property rights. HYBT has become a high-tech enterprise in Beijing in 2020, which indicates that it has been fully recognized and supported in terms of scientific and technological innovation ability. This award has laid a solid foundation for the development, industrial upgrading and brand building of HYBT products, and also enhanced the new development momentum for the biotechnology industry!
Founded in 2015, HYBT is a high-tech enterprise established by HMI group to enter the biopharmaceutical industry, mainly engaged in cannabinoid based drug research, drug development and commercial operation. It is also HMI Group's basic research and application transformation platform in the whole industrial chain of industrial hemp, and an important strategic subsidiary of biopharmaceutical field in the field of hemp. Thus HYBT undertakes the arduous mission of promoting the development of industrial hemp in the pharmaceutical field.
Since its establishment, HYBT has been driven by technology research and development, based on rich practice, and has assisted enterprises in various industries to establish sustainable competitive advantages by using industry university research cooperation development and application. On March 28, 2017, HYBT was officially approved by Beijing Association for Science and Technology and awarded the "Academician Expert Workstation", which represents HYBT's further development in promoting industry cooperation and introducing and gathering high-level talents. The establishment of academician workstation by HYBT can not only further deepen the cooperation between industry, university and research, improve the level of research and innovation of new Chinese medicine, and enhance the independent innovation ability and core competitiveness of enterprises, but also promote the development of industrial hemp industry, deepen the cooperation between industry, University and research, improve the level of research on new drug creation of traditional Chinese medicine, and enhance the independent innovation ability and core competitiveness of enterprises.
HYBT has actively carried out basic and original research work, and has a considerable number of cannabinoid patent technologies in China. HYBT is a biopharmaceutical company in a rapid growth, and is also an authoritative hemp cosmetics and beverage enterprise recognized by consumers in China's consumer market.
HYBT has a strong international vision and competitive advantage in the development of new products and new technologies, and gradually develops various terminal products and extraction technologies of non-toxic active ingredients of industrial hemp. In the future, HYBT will continue to focus on the research of non-psychoactive active ingredients of industrial hemp in the field of biomedicine and technology application. With drug research and development as the goal, practical research and active innovation will be carried out, and the legal development and utilization of industrial hemp will run through the entire industrial value chain, providing innovation assistance for the great change of industrial hemp industry.